TABLE 4.
Multivariate analysis of factors associated with primary BSI during CDI
| Variable | P value | OR | 95% CI |
|---|---|---|---|
| Ribotype 027 | <0.001 | 6.5 | 3.99–9.12 |
| CDI recurrence | <0.001 | 5.5 | 3.11–11.23 |
| Severe CDI infection | <0.001 | 8.3 | 4.76–14.12 |
| Oral vancomycin, >500 mg/day | <0.001 | 3.1 | 1.57–4.67 |